Stocks
Sanofi (SNY) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, € | ? | 11 538 000 000 | 13 510 000 000 | 11 390 000 000 | 11 033 000 000 | 12 479 000 000 | 12 626 000 000 | ||
| Changes by years, y/y, % | -35% | +17% | -16% | -3% | +13% | -6.9% | |||
Sanofi. EBITDA US GAAP, €
Sanofi. EBITDA US GAAP, changes, %
Sanofi. EBITDA US GAAP, sum by quarters, €
Sanofi (SNY) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q3 | FY2025Q2 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, € | ? | 2 770 000 000 | 4 198 000 000 | 1 889 000 000 | 3 823 000 000 | 2 716 000 000 | 12 626 000 000 | |
| Changes by years, y/y, % | +48% | -7% | +579% | -2% | ||||
| Changes by quarters, q/q, % | +392% | +52% | -55% | +102% | -29% | |||
